sheng jiang
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
Innovaderm Research Inc.
Montreal, Canada
Review Editor
Dermatologic Drugs
Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences (CAS)
Wuhan, China
Review Editor
Anti-Cancer Drugs
University of Michigan
Ann Arbor, United States
Review Editor
Cardiovascular and Hematologic Drugs
Sols-Morreale Biomedical Research Institute (IIBM), Faculty of Medicine, Autonomous University of Madrid
Madrid, Spain
Review Editor
Anti-Cancer Drugs
ETH ZĂĽrich
Zurich, Switzerland
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Laboratorio de InnovaciĂłn y Medicina de PrecisiĂłn, NĂşcleo A, Instituto Nacional de Medicina GenĂłmica
Mexico, Mexico
Review Editor
Anti-Cancer Drugs
RTI International
Durham, United States
Review Editor
Neurological Drugs
The University of Sydney
Darlington, Australia
Review Editor
Neurological Drugs
Departamento de BiofĂsica, Escola Paulista de Medicina, Universidade Federal de SĂŁo Paulo
SĂŁo Paulo, Brazil
Review Editor
Anti-Infective Agents
The University of Texas Rio Grande Valley
Edinburg, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Islamia University of Bahawalpur
Bahawalpur, Pakistan
Review Editor
Dermatologic Drugs
University of California, San Diego
La Jolla, United States
Review Editor
Neurological Drugs
Prince Sattam Bin Abdulaziz University
Al-Kharj, Saudi Arabia
Review Editor
Anti-Infective Agents
The University of Queensland
Brisbane, Australia
Review Editor
Neurological Drugs
Bioinformatics Institute (A*STAR)
Singapore, Singapore
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery